• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境中的趋化因子 CCL17 和 CCL22 与食管鳞状细胞癌中调节性 T 细胞的浸润有关。

CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.

机构信息

First Department of Surgery, University of Yamanashi, Chuo City, Yamanashi, Japan.

出版信息

Dis Esophagus. 2010 Jul;23(5):422-9. doi: 10.1111/j.1442-2050.2009.01029.x. Epub 2009 Dec 11.

DOI:10.1111/j.1442-2050.2009.01029.x
PMID:20002703
Abstract

It has been reported that an increased population of regulatory T cells (T-regs) is one of the reasons for impaired anti-tumor immunity. We investigated the frequency of Foxp3(+) T-regs in tumor-infiltrating lymphocytes (TILs) and peripheral blood lymphocytes (PBLs) of patients with esophageal squamous cell carcinoma (ESCC). Furthermore, in order to elucidate the mechanisms behind T-regs accumulation within tumors, we evaluated the relationship between CCL17 or CCL22 expression and the frequency of Foxp3(+) T-regs. CD4(+)CD25(+)Foxp3(+) T-regs as a percentage of CD4(+) cells were counted by flow cytometry. The frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells in tumors was also evaluated by flow cytometry. Moreover, an in vitro migration assay using T-regs derived from ESCC was performed in the presence of CCL17 or CCL22. The frequency of Foxp3(+) T-regs in TILs was significantly higher than that in the normal esophageal mucosa (24.6 +/- 10.0 vs 7.1 +/- 5.9%, P < 0.01). The frequency of Foxp3(+) T-regs in PBLs of ESCC patients was significantly higher than that in normal healthy donors (7.0 +/- 4.2 vs 2.5 +/- 1.0%, P < 0.01). Furthermore, the frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells within tumors was significantly higher than that of normal esophageal mucosa, and there was a significant correlation between the frequency of CCL17(+) or CCL22(+) cells and Foxp3(+) T-regs in TILs. In addition, the in vitro migration assay indicated that T-regs were significantly induced to migrate by CCL17 or CCL22. In conclusion, CCL17 and CCL22 within the tumor are related to the increased population of Foxp3(+) T-regs in ESCC.

摘要

据报道,调节性 T 细胞(T-regs)的增加是抗肿瘤免疫受损的原因之一。我们研究了食管鳞状细胞癌(ESCC)患者肿瘤浸润淋巴细胞(TILs)和外周血淋巴细胞(PBLs)中 Foxp3+T-regs 的频率。此外,为了阐明肿瘤内 T-regs 积累的机制,我们评估了 CCL17 或 CCL22 表达与 Foxp3+T-regs 频率之间的关系。通过流式细胞术计数 CD4+CD25+Foxp3+T-regs 占 CD4+细胞的百分比。通过流式细胞术还评估了肿瘤中 CD14+细胞中 CCL17+或 CCL22+细胞的频率。此外,在 CCL17 或 CCL22 存在的情况下,对来自 ESCC 的 T-regs 进行了体外迁移测定。TILs 中 Foxp3+T-regs 的频率明显高于正常食管黏膜(24.6±10.0%比 7.1±5.9%,P<0.01)。ESCC 患者 PBLs 中 Foxp3+T-regs 的频率明显高于正常健康供体(7.0±4.2%比 2.5±1.0%,P<0.01)。此外,肿瘤内 CD14+细胞中 CCL17+或 CCL22+细胞的频率明显高于正常食管黏膜,并且 TILs 中 CCL17+或 CCL22+细胞的频率与 Foxp3+T-regs 之间存在显著相关性。此外,体外迁移测定表明 CCL17 或 CCL22 可显著诱导 T-regs 迁移。总之,肿瘤内的 CCL17 和 CCL22 与 ESCC 中 Foxp3+T-regs 的增加有关。

相似文献

1
CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.肿瘤微环境中的趋化因子 CCL17 和 CCL22 与食管鳞状细胞癌中调节性 T 细胞的浸润有关。
Dis Esophagus. 2010 Jul;23(5):422-9. doi: 10.1111/j.1442-2050.2009.01029.x. Epub 2009 Dec 11.
2
CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.肿瘤微环境中的CCL17和CCL22趋化因子与胃癌中Foxp3 +调节性T细胞的积聚有关。
Int J Cancer. 2008 May 15;122(10):2286-93. doi: 10.1002/ijc.23392.
3
[The role of CD4 ⁺ CD25 ⁺ T regs and CCL17, CCL22 in the pathogenesis of head and neck squamous cell carcinoma].[CD4⁺CD25⁺调节性T细胞及CCL17、CCL22在头颈部鳞状细胞癌发病机制中的作用]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Oct 20;31(20):1557-1560. doi: 10.13201/j.issn.1001-1781.2017.20.004.
4
Frequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma.鼻窦鳞状细胞癌和鼻内翻性乳头状瘤中调节性T细胞的频率、抑制能力、募集及诱导机制
PLoS One. 2015 May 28;10(5):e0126463. doi: 10.1371/journal.pone.0126463. eCollection 2015.
5
Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.胃癌和食管癌患者外周血中调节性T细胞以及肿瘤浸润淋巴细胞数量增加。
Clin Cancer Res. 2003 Oct 1;9(12):4404-8.
6
CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion.CCL22将CD4阳性CD25阳性调节性T细胞募集到恶性胸腔积液中。
Clin Cancer Res. 2009 Apr 1;15(7):2231-7. doi: 10.1158/1078-0432.CCR-08-2641. Epub 2009 Mar 24.
7
Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu.调节性T细胞与促炎细胞因子在子宫内膜异位症环境中血管生成中的协同作用。
Hum Reprod. 2017 Jun 1;32(6):1304-1317. doi: 10.1093/humrep/dex067.
8
Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.丙型肝炎病毒诱导趋化因子 CCL17 和 CCL22 的表达,吸引调节性 T 细胞到感染部位。
J Hepatol. 2011 Mar;54(3):422-31. doi: 10.1016/j.jhep.2010.07.014. Epub 2010 Sep 26.
9
Increased frequencies of CD4+ CD25+ FOXP3+ regulatory T cells in human nasal inverted papilloma.人类鼻腔内翻性乳头状瘤中 CD4+ CD25+ FOXP3+ 调节性 T 细胞的频率增加。
Head Neck. 2011 Jul;33(7):1005-12. doi: 10.1002/hed.21581. Epub 2010 Dec 6.
10
Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.在癌前呼吸性乳头状瘤中免疫抑制:富含功能性 CD4+Foxp3+调节性 T 细胞和 PD-1/PD-L1/L2 表达。
Clin Cancer Res. 2012 Apr 1;18(7):1925-35. doi: 10.1158/1078-0432.CCR-11-2941. Epub 2012 Feb 9.

引用本文的文献

1
Chemokines: humble yet mighty players in the tumour microenvironment.趋化因子:肿瘤微环境中虽不起眼却强大的参与者。
Front Immunol. 2025 Aug 7;16:1601756. doi: 10.3389/fimmu.2025.1601756. eCollection 2025.
2
Small extracellular vesicles secreted from TGF-β1-licensed mesenchymal stromal cells reduce inflammation-associated injury following corneal alkali burn.由转化生长因子-β1许可的间充质基质细胞分泌的小细胞外囊泡可减轻角膜碱烧伤后的炎症相关损伤。
Stem Cell Res Ther. 2025 Jul 15;16(1):376. doi: 10.1186/s13287-025-04504-1.
3
Development of therapeutic cancer vaccines based on cancer immunity cycle.
基于癌症免疫循环的治疗性癌症疫苗的开发。
Front Med. 2025 Jul 14. doi: 10.1007/s11684-025-1134-6.
4
Chemokines and their receptors in the esophageal carcinoma tumor microenvironment: key factors for metastasis and progression.食管癌肿瘤微环境中的趋化因子及其受体:转移和进展的关键因素
Front Oncol. 2025 Mar 11;15:1523751. doi: 10.3389/fonc.2025.1523751. eCollection 2025.
5
The expression of CCL17 and potential prognostic value on tumor immunity in thyroid carcinoma based on bioinformatics analysis.基于生物信息学分析的甲状腺癌中CCL17的表达及其对肿瘤免疫的潜在预后价值
Sci Rep. 2024 Dec 30;14(1):31580. doi: 10.1038/s41598-024-75750-1.
6
Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer.趋化因子及其受体:食管癌肿瘤微环境治疗潜力的预测因子。
Dig Dis Sci. 2024 May;69(5):1562-1570. doi: 10.1007/s10620-024-08392-y. Epub 2024 Apr 5.
7
Hic-5 regulates extracellular matrix-associated gene expression and cytokine secretion in cancer associated fibroblasts.Hic-5调节癌症相关成纤维细胞中细胞外基质相关基因的表达和细胞因子的分泌。
Exp Cell Res. 2024 Feb 15;435(2):113930. doi: 10.1016/j.yexcr.2024.113930. Epub 2024 Jan 17.
8
Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA.下游的 STING 通路 IRF3 和 NF-κB 对细胞质 dsDNA 作出反应时,以不同的方式调节 CCL22。
Cancer Gene Ther. 2024 Jan;31(1):28-42. doi: 10.1038/s41417-023-00678-z. Epub 2023 Nov 21.
9
Tumor microenvironment signaling and therapeutics in cancer progression.肿瘤微环境信号与癌症进展中的治疗策略。
Cancer Commun (Lond). 2023 May;43(5):525-561. doi: 10.1002/cac2.12416. Epub 2023 Apr 2.
10
Efficient Redirection of NK Cells by Genetic Modification with Chemokine Receptors CCR4 and CCR2B.通过基因修饰使 NK 细胞表达趋化因子受体 CCR4 和 CCR2B 实现高效重定向。
Int J Mol Sci. 2023 Feb 4;24(4):3129. doi: 10.3390/ijms24043129.